Trials / Completed
CompletedNCT04775368
Fibromyalgia Syndrome in France: The Role of Assessment and Management of Sleep Disorders
Syndrome Fibromyalgique en France : Place de l'évaluation et de la Prise en Charge Des Troubles du Sommeil
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 601 (actual)
- Sponsor
- Centre Hospitalier Emile Roux · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The FIBOBS study is a multi-centered, observational, prospective study carried out within specialized chronic pain structures (CPS) in France. It will estimate the prevalence of sleep disorders, divided into three categories (poor quality of sleep in general, sleep apnea syndrome, restless legs syndrome), using self-questionnaires in patients with Fibromyalgia Syndrome (FMS) consulting within a CPS. The interaction between these sleep disorders and other symptoms of FMS will also be analyzed using self-administered questionnaires. Based on the hypothesis that sleep disorders associated with FMS are only imperfectly assessed and/or treated in CPS, the FIBOBS study will also interview pain physician in order to know both the diagnostic tools used and the recommended management when sleep disorders are suspected in the context of FMS. In addition, this study will provide a better understanding of the symptoms of FMS, their impact and how patients feel.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Administering diagnosis orientation questionnaires for the screening of possible sleep disorders | Several diagnosis orientation self-questionnaires will be conducted by the patient following his or her inclusion in order to detect, among other things, possible sleep disorders. |
Timeline
- Start date
- 2021-04-01
- Primary completion
- 2023-03-07
- Completion
- 2023-03-07
- First posted
- 2021-03-01
- Last updated
- 2023-05-01
Locations
46 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04775368. Inclusion in this directory is not an endorsement.